Clinical Scorecard: Comprehensive Single-Nucleus Transcriptomic Atlas of the Basal Forebrain Uncovers Varied Age-Related Pathways
At a Glance
Category
Detail
Condition
Age-related molecular changes and vulnerability to neurodegenerative diseases in the basal forebrain
Key Mechanisms
Dysregulation of cholesterol/lipid metabolism, DNA damage repair, death receptor signaling, transcriptional regulation in cholinergic neurons
Target Population
Basal forebrain cells across developmental stages and early ageing in mice, including Alzheimer's disease model (5xFAD mice)
Care Setting
Research and preclinical settings focusing on neurodegeneration and ageing
Key Highlights
Constructed a single-nucleus transcriptomic atlas of basal forebrain cells from postnatal to 15 months of age.
Identified distinct molecular regulatory patterns and ageing-related pathways in basal forebrain subclasses.
Discovered potential regulatory networks linked to cholesterol metabolism and neurodegeneration in Alzheimer's disease mouse model.
Guideline-Based Recommendations
Diagnosis
Utilize single-nucleus RNA sequencing to identify molecular signatures of basal forebrain cell types during development and ageing.
Integrate transcriptomic data to detect dysregulated pathways associated with neurodegeneration.
Management
Target specific basal forebrain subclasses and signaling pathways, such as cholesterol metabolism and DNA repair mechanisms, for therapeutic intervention.
Consider modulation of cholinergic neuron regulatory networks implicated in Alzheimer's disease.
Monitoring & Follow-up
Monitor transcriptional changes in basal forebrain cholinergic neurons over time to assess ageing progression and disease onset.
Evaluate activity of regulons such as Srebf2 and Zmiz1 as biomarkers for neurodegenerative changes.
Risks
Age-related basal forebrain atrophy correlates with cognitive decline and increased vulnerability to neurodegenerative diseases.
Loss of cholinergic neurons and dysregulation of calcium homeostasis, nicotinic receptors, and GABAergic circuits increase risk of functional impairment.
Patient & Prescribing Data
Mouse models representing normal ageing and Alzheimer's disease (5xFAD transgenic mice)
Data suggest potential for targeting cholesterol/lipid metabolism and DNA repair pathways in basal forebrain cholinergic neurons to mitigate neurodegenerative progression.
Clinical Best Practices
Apply single-nucleus transcriptomics for detailed cellular and molecular profiling in ageing research.
Focus on early detection of molecular dysregulation in basal forebrain to inform timely therapeutic strategies.
Use integrative analyses combining developmental and disease models to identify key regulatory networks.
